THE SYMCEL BOARD
Dr. Björn Varnestig
Chairman of the Board
Serial entrepreneur and venture capitalist with 30 years experience within the lifesciences. Currently CEO at Flemmingsberg Science.
Erik Walldén
Member of the Board
+30 years of international life science industry management. Previously CEO of Gyros, Affibody Holding, Biacore International and Pyrosequencing and has held senior positions at PerSeptive Biosystems, Pharmacia Biosensor and Pharmacia Biotech.
Dr. Stefan Löfås
Member of the Board
Experienced Science Director with +30 years within the life sciences tools industry. Previously Chief Scientific Officer at Biacore International and until recently the Scientific Director at GE Healthcare Bio-Sciences.
Mr. Leif Andersson
Member of the Board
Experienced entrepreneur and founder of Areim Funds. M.Sc., MBA.
Dr. Carl-Johan Spak
Member of the Board
Senior Advisor at Flerie Invest. Extensive experience from Board and management positions in pharma and lifescience companies, such as Meda and Cobra Biologics.
Dr. Stefan Larsson
Member of the Board
MD, PhD trained at Karolinska Institute and Harvard Medical School. Stefan has decades of experience on company strategy, having spent the past 25 years at Boston Consulting Group with a large focus on the healthcare sector.
Dr. Patrik Dahlen
Member of the Board
Senior level executive with 30 years experience within the life science and diagnostics industry. With a MSc and PhD in Biochemistry Patrik has previously been the CEO at Immunovia, Dako, and Perkin Elmer. Additionally, he has occupied senior level positions in top tier life science companies.